Cytokinetics reported $99.84M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Amgen AMGN:US $ 4.42B 680M
Arca Biopharma ABIO:US $ 5.68M 1.58M
Bayer BAYN:GR 12.65B 2.22B
Biogen BIIB:US $ 2648.2M 727.1M
Brainstorm Cell Therapeutics BCLI:US $ 7.59M 2.12M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Capricor Therapeutics CAPR:US $ 7.32M 509.78K
Cytokinetics CYTK:US $ 99.84M 18.14M
Eisai 4523:JP Y 176828M 34876M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Exelixis EXEL:US $ 335.72M 62.98M
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Geron GERN:US $ 28.05M 749K
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M